Clinical trials
Withdrawn Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 4D pharma plc | 1 |
| AdventHealth | 1 |
| Bristol-Myers Squibb | 1 |
| CHU de Quebec-Universite Laval | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Fox Chase Cancer Center | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hoosier Cancer Research Network | 1 |
| ImmunityBio, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 22 |
| Urinary Bladder Neoplasms | 4 |
| Breast Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasm Metastasis | 2 |
| Camurati-Engelmann Syndrome | 1 |
| Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Renal Cell | 1 |
| Colorectal Neoplasms | 1 |
Trials
Showing 76 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.